Dr. Reddy`s Laboratories Target Price

As of the most recent data, RDY shows a target price of $14. Scroll down for historical charts and peer comparison views.

If Dr. Reddy`s Laboratories moved to the average analyst target of $14, shares would be roughly 2.6% lower than $14.74. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Dr. Reddy`s Laboratories's earnings trajectory.

Besides this target price page, Stockcircle has Dr. Reddy`s Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $14) with ownership activity and broader fundamentals.

Dr. Reddy`s Laboratories's target price is $14; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.